• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院和门诊自体造血干细胞移植的比较。

A comparison of inpatient and outpatient ASCT.

作者信息

Summers N, Dawe U, Stewart D A

机构信息

Alberta Cancer Board, Calgary, Canada.

出版信息

Bone Marrow Transplant. 2000 Aug;26(4):389-95. doi: 10.1038/sj.bmt.1702534.

DOI:10.1038/sj.bmt.1702534
PMID:10982285
Abstract

Outpatient high-dose chemotherapy and autologous stem cell transplantation (ASCT) has been shown to be feasible in terms of physical morbidity and mortality outcomes, but few data exist on the psychosocial impact of delivering such aggressive therapy in this manner. The purpose of this observational study was to compare effects of inpatient (n = 20) and outpatient (n = 21) modes of care on physical status, psychological well-being, quality of life, personal finances and caregiver burden. Most patients were treated according to their preference for inpatient or outpatient care. Those choosing outpatient care were screened for eligibility according to established criteria for ambulatory management. Measures were taken at baseline, then at days 4-6, 12-16 and 30 post ASCT. Results showed that overall, the psychological, physical, social and financial outcomes of the outpatient ASCT group were comparable, to or better than inpatients. Factors that seem to be important for successful outpatient management are previous experience with cancer treatment, a satisfying quality of life, physical well-being, patient's preference for a particular mode of care and physical proximity to the treatment centre. The study results suggest that outpatient ASCT is an efficient, effective and acceptable form of care for motivated patients and caregivers who have the physical and psychological capability and desire to receive cancer treatment in this manner.

摘要

门诊高剂量化疗和自体干细胞移植(ASCT)在身体发病率和死亡率方面已被证明是可行的,但关于以这种激进方式进行治疗所产生的社会心理影响的数据却很少。这项观察性研究的目的是比较住院(n = 20)和门诊(n = 21)两种护理模式对身体状况、心理健康、生活质量、个人财务状况和照顾者负担的影响。大多数患者根据其对住院或门诊护理的偏好接受治疗。根据既定的门诊管理标准对选择门诊护理的患者进行资格筛查。在基线时进行测量,然后在ASCT后的第4 - 6天、12 - 16天和30天进行测量。结果表明,总体而言,门诊ASCT组的心理、身体、社会和财务结果与住院患者相当,甚至优于住院患者。对于成功的门诊管理似乎重要的因素包括既往癌症治疗经验、令人满意的生活质量、身体健康状况、患者对特定护理模式的偏好以及与治疗中心的实际距离。研究结果表明,门诊ASCT对于有身体和心理能力并希望以这种方式接受癌症治疗的积极患者和照顾者来说,是一种高效、有效且可接受的护理形式。

相似文献

1
A comparison of inpatient and outpatient ASCT.住院和门诊自体造血干细胞移植的比较。
Bone Marrow Transplant. 2000 Aug;26(4):389-95. doi: 10.1038/sj.bmt.1702534.
2
Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program.护理人员的短缺限制了门诊造血干细胞移植项目的使用。
Bone Marrow Transplant. 2002 Dec;30(11):741-8. doi: 10.1038/sj.bmt.1703676.
3
[The autologous transplantation of hematopoietic precursors on an outpatient basis: an analysis of its feasibility at the Hospital Clínic de Barcelona].
Med Clin (Barc). 1999 Sep 4;113(6):201-4.
4
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.复发滤泡性淋巴瘤患者的门诊自体造血干细胞移植
Ann Hematol. 2006 Oct;85(10):723-9. doi: 10.1007/s00277-006-0149-6. Epub 2006 Jul 11.
5
The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.CARES-SF用于干细胞移植后健康相关生活质量的前瞻性评估。
Psychooncology. 2003 Dec;12(8):803-13. doi: 10.1002/pon.708.
6
Reduced charges and costs associated with outpatient autologous stem cell transplantation.门诊自体干细胞移植相关的费用和成本降低。
Bone Marrow Transplant. 1998 May;21(9):927-32. doi: 10.1038/sj.bmt.1701191.
7
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.门诊和住院模式下接受自体干细胞移植的多发性骨髓瘤患者生活质量的对比评估。
Biol Blood Marrow Transplant. 2018 Mar;24(3):608-613. doi: 10.1016/j.bbmt.2017.09.021. Epub 2017 Oct 13.
8
Evaluation of the quality of life between inpatients and outpatients receiving cancer chemotherapy in Japan.日本癌症化疗住院患者与门诊患者生活质量的评估。
Anticancer Res. 2007 Mar-Apr;27(2):1127-32.
9
Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer.大剂量化疗和自体干细胞移植对转移性乳腺癌治疗中生活质量的纵向影响。
Bone Marrow Transplant. 2001 May;27(9):989-98. doi: 10.1038/sj.bmt.1703002.
10
Quality of life of cancer patients receiving inpatient and home-based palliative care.接受住院及居家姑息治疗的癌症患者的生活质量。
J Adv Nurs. 2006 Mar;53(5):524-33. doi: 10.1111/j.1365-2648.2006.03754.x.

引用本文的文献

1
Ambulatory models for autologous stem-cell transplantation: a systematic review of the health impact.门诊自体干细胞移植模型:对健康影响的系统评价。
Front Immunol. 2024 Jul 16;15:1419186. doi: 10.3389/fimmu.2024.1419186. eCollection 2024.
2
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma.临床医生和管理人员对复发或难治性多发性骨髓瘤患者门诊应用 cilta-cabtagene autoleucel 的看法。
Front Immunol. 2024 Jun 10;15:1405452. doi: 10.3389/fimmu.2024.1405452. eCollection 2024.
3
Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration.
嵌合抗原受体T细胞疗法:门诊给药的挑战与框架
EJHaem. 2021 Nov 19;3(Suppl 1):54-60. doi: 10.1002/jha2.333. eCollection 2022 Jan.
4
Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs.造血干细胞移植的医院和门诊模式:对健康结果、护理体验和成本的比较研究的系统评价。
PLoS One. 2021 Aug 12;16(8):e0254135. doi: 10.1371/journal.pone.0254135. eCollection 2021.
5
Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art.新型药物时代的多发性骨髓瘤门诊移植项目:最新进展
Front Oncol. 2020 Nov 11;10:592487. doi: 10.3389/fonc.2020.592487. eCollection 2020.
6
Exploring the caregiver's experience in an innovative homebound hematopoietic stem cell transplantation program.探索创新的居家造血干细胞移植项目中护理人员的体验。
Palliat Support Care. 2021 Aug;19(4):397-404. doi: 10.1017/S1478951520000954.
7
Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.基于治疗场所的复发或难治性大 B 细胞淋巴瘤患者嵌合抗原受体 T 细胞治疗的经济学评价。
JAMA Netw Open. 2020 Apr 1;3(4):e202072. doi: 10.1001/jamanetworkopen.2020.2072.
8
A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions.异基因造血干细胞移植期间照顾者负担的范围综述:经验教训与未来方向
Bone Marrow Transplant. 2016 Nov;51(11):1416-1422. doi: 10.1038/bmt.2016.164. Epub 2016 Jun 13.
9
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.意大利多发性骨髓瘤门诊自体干细胞移植管理共识会议
Bone Marrow Transplant. 2016 Aug;51(8):1032-40. doi: 10.1038/bmt.2016.79. Epub 2016 Apr 4.
10
Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.强化诱导或挽救化疗后急性髓系白血病或骨髓增生异常综合征门诊管理的资源利用和安全性:一项非随机临床对比分析。
JAMA Oncol. 2015 Nov;1(8):1120-7. doi: 10.1001/jamaoncol.2015.2969.